Cited by 13Glaucoma and retinal disordersRetinal and Optic ConditionsAcute Ischemic Stroke Management

Acute changes in ganglion cell layer thickness in ischemic optic neuropathy compared to optic neuritis using optical coherence tomography

Open access
MacIntosh, Peter W.·2020·International Journal of Ophthalmology

Abstract

AIM: To elucidate the changes of different ganglion cell layer (GCL) thinning patterns between the optic neuritis (ON) and non-arteritic anterior ischemic optic neuropathy (NAION). METHODS: A prospective, observational study was conducted to evaluate the timing of GCL changes between acute ON and NAION using optical coherence tomography. RESULTS: Thinning on optical coherence tomography in the NAION group occurs as early as 11d after symptomatic onset of vision loss and follows an altitudinal pattern. The mean superior-inferior GCL thickness difference in the NAION cohort was clinically significant at 5.7 μm in the NAION cohort compared to controls of 0.8 μm (P=0.032), but not significant in the ON group compared to controls with both groups measuring 1.1 μm. Global thinning was significant for the ON group compared to controls at 7.2 μm (P=0.011) but not the NAION group compared to controls at 1.35 μm. CONCLUSION: These findings suggest that future treatments for NAION should be given early, and possibly before 11d in order to prevent GCL and irreversible vision loss.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18240/ijo.2020.01.17

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Assessing GCIPL thickness maps for patterns of regional macular injury might provide insight into vascular etiologies of optic neuropathy, such as when altitudinal thinning is present, or optic chiasm, optic tract, thalamic and/or retrogeniculate pathology.

    “Assessing the GCIPL thickness maps for patterns of regional macular injury might provide insight into vascular etiologies of optic neuropathy, such as when altitudinal thinning is present, or optic chiasm, optic tract, thalamic and/or retrogeniculate pathology. 80 -83”

    From The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis (2025) · cites this paper as [80]

    The Discussion (page not provided) reports altitudinal macular ganglion-cell-layer thinning in non-arteritic anterior ischemic optic neuropathy and says this pattern may help distinguish it from optic neuritis. It does not address whether GCIPL maps provide insight into optic chiasm, optic tract, thalamic, or retrogeniculate pathology, so that extension is unsupported by this paper. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 20

  1. Dhiman R, Singh D, Gantayala SP, Ganesan VL, Sharma P, Saxena R. Neuro-ophthalmology at a tertiary eye care centre in India. J Neuro - Ophthalmol 2018;38(3):308-311.
  2. Aggarwal D, Tan O, Huang D, Sadun AA. Patterns of ganglion cell complex and nerve fiber layer loss in nonarteritic ischemic optic neuropathy by Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53(8):4539-4545.
  3. Warner JE, Lessell S, Rizzo JF 3rd, Newman NJ. Does optic disc appearance distinguish ischemic optic neuropathy from optic neuritis? Arch Ophthalmol 1997;115(11):1408-1410.
  4. Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical coherence tomography (OCT): imaging the visual pathway as a model for Ganglion cell layer changes in ischemic optic neuropathy and optic neuritis Int J Ophthalmol, Vol. 13, No. 1, Jan.18, 2020 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com neurodegeneration. Neurotherapeutics 2011;8(1):117-132.
  5. Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1993; 111(2):231-234.
  6. Gerling J, Meyer JH, Kommerell G. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol 1998;236(3):188-192.
  7. Horowitz J, Fishelzon-Arev T, Rath EZ, Segev E, Geyer O. Comparison of optic nerve head topography findings in eyes with non-arteritic anterior ischemic optic neuropathy and eyes with glaucoma. Graefes Arch Clin Exp Ophthalmol 2010;248(6):845-851.
  8. Ho JK, Stanford MP, Shariati MA, Dalal R, Liao YJ. Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation. Invest Ophthalmol Vis Sci 2013;54(9):5981-5988.
  9. Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond) 2015;29(1):65-79.
  10. Erlich-Malona N, Mendoza-Santiesteban CE, Hedges TR 3rd, Patel N, Monaco C, Cole E. Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis. Acta Ophthalmol 2016;94(8): e721-e726.
  11. De Dompablo E, García-Montesinos J, Muñoz-Negrete FJ, Rebolleda G. Ganglion cell analysis at acute episode of nonarteritic anterior ischemic optic neuropathy to predict irreversible damage. A prospective study. Graefes Arch Clin Exp Ophthalmol 2016;254(9):1793-1800.
  12. Contreras I, Noval S, Rebolleda G, Munoz-Negrete FJ. Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography. Ophthalmol 2007;114(12):2338-2344.
  13. Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome SD, Balcer LJ, Frohman EM, Calabresi PA. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology 2013;80(1):47-54.
  14. Gabilondo I, Martínez-Lapiscina EH, Fraga-Pumar E, Ortiz-Perez S, Torres-Torres R, Andorra M, Llufriu S, Zubizarreta I, Saiz A, Sanchez- Dalmau B, Villoslada P. Dynamics of retinal injury after acute optic neuritis. Ann Neurol 2015;77(3):517-528.
  15. Kupersmith MJ, Garvin MK, Wang JK, Durbin M, Kardon R. Retinal ganglion cell layer thinning within one month of presentation for optic neuritis. Mult Scler 2016;22(5):641-648.
  16. Keller J, Oakley JD, Russakoff DB, Andorrà-Inglés M, Villoslada P, Sánchez-Dalmau BF. Changes in macular layers in the early course of non-arteritic ischaemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2016;254(3):561-567.
  17. Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ. Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol 2011;31(3):260-264.
  18. Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993;116(6):759-764.
  19. Levin LA, Danesh-Meyer HV. Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2008;126(11):1582-1585.
  20. Bernstein SL, Johnson MA, Miller NR. Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog Retin Eye Res 2011;30(3):167-187.

Cited by

Sorted by citations

Authors
MacIntosh, P. W.
Affiliations
University of Illinois Chicago (US)
Corresponding author
MacIntosh, Peter W.
Venue
International Journal of Ophthalmology
Published
2020-01-18
Volume
13
Issue
1
Pages
120-123
ISSN
  • 2222-3959 (ISSN-L)
  • 2227-4898
OpenAlex
W2996532655
Cited by
13
References
0
Citations by year
2026: 4 · 2025: 3 · 2024: 2 · 2022: 1 · 2021: 2 · 2020: 1
FWCI
0.98
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • International Journal of Ophthalmology (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Research to Prevent Blindness (P30 EY001792, EY001792)
  • National Eye Institute (EY001792, P30EY001792)
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal and Optic Conditions
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
Keywords
nonarteritic anterior ischemic optic neuropathy, optic neuritis, ganglion cell layer thickness, early treatment timing, blindness prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review